Page de résultat 2 pour Industrie : Fabricants de médicaments - Général Marché boursier - Cotations et cours
Liste de toutes les actions et titres avec cours, capitalisations boursières, ratios P/E et BPA
Tous les pays
- {{country.name}}
- Tous les pays
- États-Unis (50)
- Argentine (13)
- Australie (1)
- L'Autriche (13)
- Brésil (14)
- Canada (2)
- Chili (4)
- Chine (22)
- Finlande (2)
- France (3)
- Allemagne (58)
- Hong Kong (4)
- Hongrie (1)
- Inde (20)
- Indonésie (1)
- Italie (5)
- Japon (9)
- Mexique (14)
- Singapour (1)
- Corée du Sud (3)
- Espagne (1)
- Suède (3)
- Suisse (6)
- Taïwan (1)
- Turquie (1)
- Royaume-Uni (20)
Tous marchés
- {{item.name}}
- Tous marchés
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (4)
- IOB (17)
- Istanbul (1)
- Jakarta (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (9)
- OTC Markets OTCPK (30)
- OTC Markets OTCQX (3)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (11)
- Shenzhen (11)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
Tous secteur
- {{item.name}}
- Tous secteur
- Soins de santé (279)
Fabricants de médicaments - Général (279)
- {{item.name}}
- Toutes les industries
- Apports Agricoles (323)
- Matériaux de construction (471)
- Produits chimiques (605)
- Produits chimiques spécialisés (1353)
- Production de bois de charpente et du bois (160)
- Papiers et produits en papier (269)
- Aluminium (141)
- Cuivre (216)
- Autres métaux industriels et mines (2765)
- Or (1700)
- Argent (84)
- Autres métaux précieux et mines (660)
- Charbon à coke (71)
- Acier (744)
- Concessionnaires automobiles et de camions (212)
- Fabricants d'automobiles (388)
- Pièces d'automobiles (1166)
- Véhicules de plaisance (85)
- Ameublement, équipements et appareils électroménagers (507)
- Construction Résidentielle (214)
- Fabrication de textiles (520)
- Fabrication de vêtements (444)
- Chaussures et Accessoires (208)
- Emballage et Conteneurs (481)
- Services Personnels (140)
- Restaurants (539)
- Vêtements au détail (289)
- Grands Magasins (276)
- Aménagement intérieur - commerce de détail (106)
- Produits de luxe (260)
- Vente au détail sur Internet (408)
- Vente au détail de spécialité (547)
- Jeux d'argent (205)
- Loisirs (411)
- Logement (321)
- Station de Loisirs et casinos (188)
- Services de voyage (192)
- Gestion d'actifs (1966)
- Banques - Diversifiées (308)
- Banques - Régionales (2297)
- Financement hypothécaire (171)
- Marchés des Capitaux (888)
- Données financières et bourses (151)
- Assurance - Vie (260)
- Assurance - IARD (270)
- Assurance - Réassurance (74)
- Assurance - Spécialité (72)
- Courtiers d'assurances (67)
- Assurance - diversifié (306)
- Sociétés écrans (1820)
- Conglomérats financiers (100)
- Services de Crédit (660)
- Immobilier - Développement (966)
- Services Immobiliers (1145)
- Immobilier - Diversifié (316)
- FPI - Soins médicaux (64)
- FPI - Hôtel et Motel (86)
- FPI - Industriel (141)
- FPI - Bureau (169)
- FPI - Résidentiel (108)
- FPI - Vente au détail (230)
- FPI - Hypothèque (130)
- FPI - Spécialité (83)
- FPI - Diversifié (332)
- Boissons - Brasseurs (162)
- Boissons - Vignobles et Distilleries (242)
- Boissons - Non Alcoolisées (217)
- Confiseurs (170)
- Produits agricoles (610)
- Produits domestiques et personnels (523)
- Aliments emballés (1270)
- Services d'éducation et de formation (305)
- Magasins d'escompte (97)
- Distribution alimentaire (210)
- Epiceries (233)
- Tabac (105)
- Biotechnologie (2611)
- Fabricants de médicaments - Général (279)
- Fabricants de médicaments - de spécialité et génériques (1705)
- Plans de soins de santé (57)
- Établissements de soins médicaux (553)
- Détaillants Pharmaceutiques (155)
- Services d'information sur la santé (419)
- Dispositifs médicaux (913)
- Instruments médicaux et des fournitures (501)
- Diagnostiques et Recherche (427)
- Distribution médicale (138)
- Services publics - Producteurs indépendants d'électricité (170)
- Services publics - Renouvelables (561)
- Services publics - Eau réglementée (173)
- Services Publics - produits électriques réglementés (468)
- Services publics - Gaz réglementé (205)
- Services publics - diversifiés (214)
- Services de Télécommunication (910)
- Agences de Publicité (508)
- Publication (259)
- Diffusion (213)
- Divertissement (679)
- Contenu d'internet et information (530)
- Jeux électroniques et multimédia (484)
- Forage pétrolier et gazier (80)
- Exploration et Production du Pétrole et Gaz (1185)
- Pétrole et Gaz Intégrés (246)
- Pétrole et Gaz-Midstream (230)
- Pétrole et Gaz - Raffinage et Marketing (278)
- Service et l'équipement du pétrole et Gaz (480)
- Charbon thermique (229)
- Uranium (140)
- Aérospatial et Défense (560)
- Services aux entreprises spécialisées (640)
- Services d’experts-conseils (195)
- Services de location (219)
- Services de sécurité et de protection (267)
- Services de dotation en personnel et d’emploi (252)
- Conglomérats (723)
- Ingénierie et Construction (1492)
- Opérations d'infrastructure (156)
- Produits de construction et équipement (513)
- Machinerie agricole et de construction lourde (376)
- Distribution industrielle (235)
- Équipement et fournitures d’entreprise (142)
- Machines Industries spécialisées (1720)
- Fabrication de métal (393)
- Les contrôles de la pollution et de traitement (265)
- Outils et accessoires (240)
- Équipement et pièces électriques (897)
- Aéroports et services aériens (135)
- Compagnies aériennes (229)
- Chemins de fer (260)
- Transport maritime (505)
- Camionnage (99)
- Fret et logistique intégrés (388)
- Gestion des déchets (354)
- Services des technologies de l'information (1178)
- Logiciel - Application (2113)
- Logiciel - Infrastructure (955)
- Matériel de communication (731)
- Matériel Informatique (434)
- Produits électroniques à l'usage des consommateurs (282)
- Composants électroniques (971)
- Électronique et distribution informatique (239)
- Instruments scientifiques et techniques (347)
- Equipements et matériaux semi-conducteurs (350)
- Semi-conducteurs (611)
- Solaire (222)
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Johnson & Johnson JNJB34.SA | $57.81 11.72 USD |
+0.49
|
$2.1T 426.56B USD | $6.58K 1.33K USD | $57.55 11.66 USD | $58.49 11.85 USD | $2.1T 426.56B USD | 16.85 | $3.43 0.7 USD | |
| Johnson & Johnson JNJ.MX | $2,948.52 174.59 USD |
+0.51
|
$7.11T 421.15B USD | $1.06K 62.71 USD | $2,931.94 173.61 USD | $2,948.69 174.6 USD | $7.11T 421.15B USD | 16.97 | $173.67 10.28 USD | |
| Johnson & Johnson JNJ.SN | $148.27 — |
0
|
$396.76B — | $0 — | $145.55 — | $145.55 — | $396.76B — | 22.43 | $6.61 — | |
| AbbVie Inc. ABBV34.SA | $63.6 12.89 USD |
-1.12
|
$1.85T 375.24B USD | $10K 2.03K USD | $63.6 12.89 USD | $65.73 13.32 USD | $1.85T 375.24B USD | 75.71 | $0.84 0.17 USD | |
| AbbVie Inc. ABBV.MX | $3,494 206.89 USD |
0
|
$6.26T 370.48B USD | $139 8.23 USD | $3,494 206.89 USD | $3,494 206.89 USD | $6.26T 370.48B USD | 77.52 | $45.07 2.67 USD | |
| Johnson & Johnson JNJ.F | $134.96 147.53 USD |
-0.07
|
$326.2B 356.58B USD | $180 196.76 USD | $134 146.48 USD | $135.6 148.23 USD | $326.2B 356.58B USD | 16.95 | $7.96 8.7 USD | |
| Johnson & Johnson JNJ.VI | $134.4 146.92 USD |
+0.15
|
$326.2B 356.58B USD | $68 74.33 USD | $134.4 146.92 USD | $135.28 147.88 USD | $326.2B 356.58B USD | 16.94 | $7.93 8.67 USD | |
| AbbVie Inc. 4AB.DE | $161.2 176.21 USD |
+0.62
|
$286.96B 313.68B USD | $460 502.84 USD | $160 174.9 USD | $161.6 176.65 USD | $286.96B 313.68B USD | 77.50 | $2.08 2.27 USD | |
| AbbVie Inc. 4AB.F | $161 175.99 USD |
+0.63
|
$286.96B 313.68B USD | $138 150.85 USD | $160.4 175.34 USD | $162.2 177.31 USD | $286.96B 313.68B USD | 77.40 | $2.08 2.27 USD | |
| AbbVie Inc. ABBV.VI | $161.4 176.43 USD |
+0.75
|
$286.96B 313.68B USD | $0 0 USD | $161 175.99 USD | $161.6 176.65 USD | $286.96B 313.68B USD | 77.97 | $2.07 2.26 USD | |
| Novartis AG NVS.BA | $32,550 38.48 USD |
+0.08
|
$251.27T 297.01B USD | $1 0 USD | $32,550 38.48 USD | $32,550 38.48 USD | $251.27T 297.01B USD | 2.24 | $14.5K 17.14 USD | |
| AstraZeneca PLC AZN.BA | $40,975 48.43 USD |
+0.86
|
$246.67T 291.57B USD | $1.11K 1.32 USD | $40,600 47.99 USD | $41,000 48.46 USD | $246.67T 291.57B USD | 7.25 | $5.65K 6.67 USD | |
| Roche Holding AG ROGN.MX | $6,035.68 357.39 USD |
+1.47
|
$4.87T 288.07B USD | $729 43.17 USD | $6,012.15 355.99 USD | $6,087.26 360.44 USD | $4.87T 288.07B USD | 25.12 | $240.22 14.22 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| Merck & Co., Inc. MRK.BA | $18,000 21.28 USD |
-0.41
|
$221.36T 261.66B USD | $3.06K 3.62 USD | $17,825 21.07 USD | $18,075 21.37 USD | $221.36T 261.66B USD | 0.23 | $78.18K 92.41 USD | |
| Novartis AG N1VS34.SA | $63.84 12.94 USD |
+3.05
|
$1.26T 256.32B USD | $32 6.49 USD | $63.84 12.94 USD | $64.4 13.05 USD | $1.26T 256.32B USD | 17.49 | $3.65 0.74 USD | |
| Novartis AG NVSN.MX | $2,092.19 123.88 USD |
0
|
$4.27T 253.07B USD | $0 0 USD | $2,092.19 123.88 USD | $2,092.19 123.88 USD | $4.27T 253.07B USD | 16.97 | $123.23 7.3 USD | |
| Roche Holding AG RHHBF | $331 — |
0
|
$251.71B — | $37 — | $325.88 — | $328 — | $251.71B — | 26.52 | $12.48 — | |
| AstraZeneca PLC A1ZN34.SA | $65.59 13.29 USD |
-0.14
|
$1.24T 251.63B USD | $3.6K 730.47 USD | $65.59 13.29 USD | $66.73 13.53 USD | $1.24T 251.63B USD | 27.67 | $2.37 0.48 USD | |
| AstraZeneca PLC AZNN.MX | $1,345 79.64 USD |
0
|
$4.2T 248.43B USD | $0 0 USD | $1,345 79.64 USD | $1,345 79.64 USD | $4.2T 248.43B USD | 28.00 | $48.02 2.84 USD | |
| Roche Holding AG RHO6.F | $34.41 37.61 USD |
-0.52
|
$223.13B 243.91B USD | $28 30.61 USD | $34.41 37.61 USD | $35.06 38.33 USD | $223.13B 243.91B USD | 24.93 | $1.38 1.51 USD | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| Merck & Co., Inc. MRCK34.SA | $54.18 10.98 USD |
-1.31
|
$1.11T 225.82B USD | $7.91K 1.6K USD | $54.18 10.98 USD | $55.5 11.25 USD | $1.11T 225.82B USD | 11.01 | $4.92 1 USD | |
| Merck & Co., Inc. MRK.MX | $1,495 88.52 USD |
-0.4
|
$3.77T 222.95B USD | $3.93K 232.88 USD | $1,489.46 88.19 USD | $1,500 88.82 USD | $3.77T 222.95B USD | 11.24 | $132.91 7.87 USD | |
| AstraZeneca PLC AZNCF | $143.25 — |
0
|
$222.07B — | $100 — | $141 — | $141 — | $222.07B — | 28.82 | $4.97 — | |
| Novartis AG NOTA.F | $98.6 107.78 USD |
+1.02
|
$196.02B 214.27B USD | $40 43.73 USD | $97.2 106.25 USD | $98.6 107.78 USD | $196.02B 214.27B USD | 17.42 | $5.66 6.19 USD | |
| AstraZeneca PLC ZEG.F | $124.35 135.93 USD |
+0.77
|
$192.77B 210.72B USD | $280 306.08 USD | $123.2 134.67 USD | $124.9 136.53 USD | $192.77B 210.72B USD | 28.26 | $4.4 4.81 USD | |
| AstraZeneca PLC ZEGA.F | $61 66.68 USD |
0
|
$192.43B 210.35B USD | $784 857.02 USD | $61 66.68 USD | $61.5 67.23 USD | $192.43B 210.35B USD | 27.72 | $2.2 2.4 USD | |
| Merck & Co., Inc. MRK.SN | $78.71 — |
+2.67
|
$200.02B — | $0 — | $78.71 — | $78.71 — | $200.02B — | 11.44 | $6.88 — | |
| Amgen Inc. AMGN.BA | $10,475 12.38 USD |
-0.24
|
$165.99T 196.2B USD | $296 0.35 USD | $10,400 12.29 USD | $10,575 12.5 USD | $165.99T 196.2B USD | 0.16 | $62.33K 73.67 USD | |
| Merck & Co., Inc. MRK.VI | $68.2 74.55 USD |
+0.15
|
$172.69B 188.77B USD | $270 295.15 USD | $68.2 74.55 USD | $69 75.43 USD | $172.69B 188.77B USD | 11.23 | $6.07 6.64 USD | |
| Merck & Co., Inc. 6MK.DE | $68.3 74.66 USD |
+0.15
|
$172.69B 188.77B USD | $2.39K 2.61K USD | $68 74.33 USD | $69 75.43 USD | $172.69B 188.77B USD | 11.19 | $6.1 6.67 USD | |
| Merck & Co., Inc. 6MK.F | $68.4 74.77 USD |
+0.15
|
$172.69B 188.77B USD | $403 440.53 USD | $68.1 74.44 USD | $68.9 75.32 USD | $172.69B 188.77B USD | 11.21 | $6.1 6.67 USD | |
| Gilead Sciences, Inc. GILD.BA | $31,175 36.85 USD |
+0.89
|
$151.77T 179.4B USD | $303 0.36 USD | $30,675 36.26 USD | $31,250 36.94 USD | $151.77T 179.4B USD | 5.76 | $5.41K 6.39 USD | |
| Pfizer Inc. PFE.BA | $6,790 8.03 USD |
+1.65
|
$150.66T 178.08B USD | $6.68K 7.9 USD | $6,650 7.86 USD | $6,800 8.04 USD | $150.66T 178.08B USD | 2.16 | $3.14K 3.71 USD | |
| Amgen Inc. AMGN34.SA | $55.11 11.17 USD |
-0.02
|
$835.42B 169.33B USD | $47 9.53 USD | $55.11 11.17 USD | $55.52 11.25 USD | $835.42B 169.33B USD | 24.60 | $2.24 0.45 USD | |
| Amgen Inc. AMGN.MX | $5,300 313.82 USD |
0
|
$2.85T 168.75B USD | $0 0 USD | $5,300 313.82 USD | $5,300 313.82 USD | $2.85T 168.75B USD | 25.00 | $212 12.55 USD | |
| Gilead Sciences, Inc. GILD34.SA | $305.57 61.93 USD |
0
|
$763.86B 154.82B USD | $0 0 USD | $305.57 61.93 USD | $305.57 61.93 USD | $763.86B 154.82B USD | 22.46 | $13.6 2.76 USD | |
| Pfizer Inc. PFIZ34.SA | $32.59 6.61 USD |
+0.18
|
$758.27B 153.69B USD | $6.7K 1.36K USD | $32.59 6.61 USD | $33.1 6.71 USD | $758.27B 153.69B USD | 16.54 | $1.97 0.4 USD | |
| Gilead Sciences, Inc. GILD.MX | $1,982 117.36 USD |
0
|
$2.58T 152.85B USD | $0 0 USD | $1,982 117.36 USD | $1,982 117.36 USD | $2.58T 152.85B USD | 21.55 | $91.96 5.45 USD | |
| Pfizer Inc. PFE.MX | $449.98 26.64 USD |
+0.89
|
$2.56T 151.74B USD | $291 17.23 USD | $444.96 26.35 USD | $451 26.7 USD | $2.56T 151.74B USD | 16.86 | $26.68 1.58 USD | |
| Amgen Inc. 0R0T.IL | $271.5 — |
+0.56
|
$148.79B — | $225 — | $269 — | $272.01 — | $148.79B — | 18.29 | $14.84 — | |
| Amgen Inc. AMG.DE | $239.45 261.75 USD |
+0.15
|
$129.49B 141.55B USD | $161 175.99 USD | $238.2 260.38 USD | $240.65 263.06 USD | $129.49B 141.55B USD | 24.63 | $9.72 10.63 USD | |
| Amgen Inc. AMGN.VI | $239.25 261.53 USD |
+0.21
|
$129.49B 141.55B USD | $72 78.71 USD | $237.95 260.11 USD | $240.45 262.84 USD | $129.49B 141.55B USD | 24.69 | $9.69 10.59 USD | |
| Amgen Inc. AMG.F | $238.75 260.99 USD |
-1.1
|
$129.49B 141.55B USD | $34 37.17 USD | $237.4 259.51 USD | $238.95 261.2 USD | $129.49B 141.55B USD | 24.56 | $9.72 10.63 USD | |
| Gilead Sciences, Inc. GILD.SN | $95.78 — |
+6.77
|
$138.54B — | $0 — | $95.78 — | $95.78 — | $138.54B — | 20.12 | $4.76 — | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Gilead Sciences, Inc. GILD.VI | $93.68 102.4 USD |
-0.55
|
$118.4B 129.42B USD | $0 0 USD | $93.86 102.6 USD | $94.18 102.95 USD | $118.4B 129.42B USD | 22.30 | $4.2 4.59 USD | |
| Gilead Sciences, Inc. GIS.DE | $93.8 102.54 USD |
-0.72
|
$118.4B 129.42B USD | $1.01K 1.1K USD | $92.86 101.51 USD | $94.48 103.28 USD | $118.4B 129.42B USD | 22.22 | $4.22 4.61 USD | |
| Gilead Sciences, Inc. GIS.F | $94.05 102.81 USD |
-0.16
|
$118.4B 129.42B USD | $460 502.84 USD | $94.05 102.81 USD | $94.07 102.83 USD | $118.4B 129.42B USD | 22.28 | $4.22 4.61 USD | |
| Pfizer Inc. PFE.VI | $20.43 22.33 USD |
+0.94
|
$117.53B 128.48B USD | $1.83K 2K USD | $20.35 22.24 USD | $20.55 22.46 USD | $117.53B 128.48B USD | 16.74 | $1.22 1.33 USD | |
| Pfizer Inc. PFEB.F | $6.5 7.11 USD |
0
|
$117.53B 128.48B USD | $5 5.47 USD | $6.5 7.11 USD | $6.5 7.11 USD | $117.53B 128.48B USD | 15.47 | $0.42 0.46 USD | |
| Bristol-Myers Squibb Company BMY.BA | $18,200 21.51 USD |
-0.14
|
$108.34T 128.06B USD | $74 0.09 USD | $18,000 21.28 USD | $18,200 21.51 USD | $108.34T 128.06B USD | 5.97 | $3.04K 3.6 USD | |
| Pfizer Inc. PFE.SN | $22.18 — |
-14.89
|
$126.1B — | $0 — | $22.18 — | $22.18 — | $126.1B — | 16.07 | $1.38 — | |
| Sanofi SANO.VI | $91.51 100.03 USD |
-1.52
|
$113.67B 124.25B USD | $97 106.03 USD | $91.51 100.03 USD | $93.52 102.23 USD | $113.67B 124.25B USD | 18.33 | $4.99 5.45 USD | |
| Sanofi SNW.F | $92.2 100.79 USD |
-1.26
|
$113.67B 124.25B USD | $242 264.54 USD | $91.5 100.02 USD | $93.07 101.74 USD | $113.67B 124.25B USD | 18.47 | $4.99 5.45 USD | |
| Sanofi SNW2.F | $45.6 49.85 USD |
-1.3
|
$113.66B 124.25B USD | $120 131.18 USD | $45.6 49.85 USD | $46.2 50.5 USD | $113.66B 124.25B USD | 18.31 | $2.49 2.72 USD | |
| Bristol-Myers Squibb Company BMY.MX | $930 55.07 USD |
0
|
$1.89T 112.07B USD | $0 0 USD | $930 55.07 USD | $930 55.07 USD | $1.89T 112.07B USD | 17.95 | $51.8 3.07 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $267.47 54.21 USD |
0
|
$545.29B 110.52B USD | $0 0 USD | $267.47 54.21 USD | $267.47 54.21 USD | $545.29B 110.52B USD | 17.44 | $15.33 3.11 USD | |
| GSK plc GSK.BA | $11,175 13.21 USD |
-0.67
|
$90.69T 107.2B USD | $45 0.05 USD | $11,175 13.21 USD | $11,250 13.3 USD | $90.69T 107.2B USD | 19.26 | $579.98 0.69 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| Bristol-Myers Squibb Company BRM.DE | $41.31 45.15 USD |
-0.07
|
$84.52B 92.39B USD | $945 1.03K USD | $41.06 44.88 USD | $42.1 46.02 USD | $84.52B 92.39B USD | 17.35 | $2.38 2.6 USD | |
| Bristol-Myers Squibb Company BRM.F | $41.5 45.37 USD |
+0.48
|
$84.52B 92.39B USD | $115 125.71 USD | $41.28 45.12 USD | $41.71 45.59 USD | $84.52B 92.39B USD | 17.51 | $2.37 2.59 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $41.27 45.11 USD |
+0.02
|
$84.52B 92.39B USD | $0 0 USD | $41.27 45.11 USD | $41.78 45.67 USD | $84.52B 92.39B USD | 17.48 | $2.36 2.58 USD | |
| GSK plc GSKN.MX | $711 42.1 USD |
+3.18
|
$1.55T 91.63B USD | $0 0 USD | $711 42.1 USD | $711 42.1 USD | $1.55T 91.63B USD | 18.00 | $39.49 2.34 USD | |
| GSK plc G1SK34.SA | $43.74 8.87 USD |
-0.59
|
$443.83B 89.96B USD | $161 32.63 USD | $43.74 8.87 USD | $44.4 9 USD | $443.83B 89.96B USD | 18.69 | $2.34 0.47 USD | |
| Chugai Pharmaceutical CHGCF | $53.96 — |
0
|
$88.8B — | $200 — | $52 — | $52 — | $88.8B — | 31.19 | $1.73 — | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $45.96 50.24 USD |
+0.31
|
$76.65B 83.79B USD | $22 24.05 USD | $45.96 50.24 USD | $46.17 50.47 USD | $76.65B 83.79B USD | 29.84 | $1.54 1.68 USD | |
| GSK GLAXF | $19.33 — |
0
|
$78.44B — | $250 — | $19 — | $19 — | $78.44B — | 18.95 | $1.02 — | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $23.38 25.56 USD |
+2.23
|
$43.55B 47.6B USD | $1.5K 1.64K USD | $22.85 24.98 USD | $23.38 25.56 USD | $43.55B 47.6B USD | 24.35 | $0.96 1.05 USD | |
| Bayer Aktiengesellschaft BAYZF | $27.5 — |
+3.07
|
$27.12B — | $3.88K — | $27.5 — | $27.5 — | $27.12B — | 0 | -$3.76 — | |
| Bayer Aktiengesellschaft BAYER.BD | $9,859 27.27 USD |
+0.6
|
$9.71T 26.84B USD | $526 1.45 USD | $9,768 27.02 USD | $10,072 27.86 USD | $9.71T 26.84B USD | 0 | -$1,337 -3.7 USD | |
| Bayer Aktiengesellschaft BAYA.F | $5.95 6.5 USD |
-4.8
|
$24.04B 26.28B USD | $110 120.24 USD | $5.95 6.5 USD | $6.4 7 USD | $24.04B 26.28B USD | 0 | -$0.83 -0.9 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $24.45 26.73 USD |
+1.37
|
$24.04B 26.28B USD | $6.59K 7.2K USD | $24.06 26.3 USD | $25.04 27.37 USD | $24.04B 26.28B USD | 0 | -$3.32 -3.6 USD | |
| Biogen Inc. BIIB.BA | $11,200 13.24 USD |
-0.44
|
$20.95T 24.76B USD | $372 0.44 USD | $11,100 13.12 USD | $11,200 13.24 USD | $20.95T 24.76B USD | 0.97 | $11.5K 13.59 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $40.4 44.16 USD |
-0.49
|
$21.64B 23.65B USD | $180 196.76 USD | $40.4 44.16 USD | $40.8 44.6 USD | $21.64B 23.65B USD | 10.09 | $4 4.37 USD | |
| Biogen Inc. BIIB34.SA | $121.92 24.71 USD |
0
|
$107.62B 21.81B USD | $0 0 USD | $121.92 24.71 USD | $121.92 24.71 USD | $107.62B 21.81B USD | 12.68 | $9.61 1.95 USD | |
| Biogen Inc. BIIB.MX | $2,445 144.77 USD |
0
|
$358.26B 21.21B USD | $0 0 USD | $2,445 144.77 USD | $2,445 144.77 USD | $358.26B 21.21B USD | 12.50 | $195.6 11.58 USD | |
| Biogen Inc. IDP.DE | $110.15 120.41 USD |
-0.9
|
$16.34B 17.86B USD | $167 182.55 USD | $109.5 119.7 USD | $112.6 123.09 USD | $16.34B 17.86B USD | 12.27 | $8.97 9.81 USD | |
| Biogen Inc. IDP.F | $110 120.24 USD |
-0.99
|
$16.34B 17.86B USD | $200 218.63 USD | $110 120.24 USD | $110.9 121.23 USD | $16.34B 17.86B USD | 12.24 | $8.98 9.82 USD | |
| Biogen Inc. BIIB.VI | $110.05 120.3 USD |
-1.03
|
$16.34B 17.86B USD | $7 7.65 USD | $110.05 120.3 USD | $111.8 122.21 USD | $16.34B 17.86B USD | 12.30 | $8.94 9.77 USD | |
| Astellas Pharma ALPMF | $9.55 — |
0
|
$17.33B — | $224 — | $9.55 — | $9.55 — | $17.33B — | 47.75 | $0.2 — | |
| Astellas Pharma Inc. YPHA.F | $8.25 9.02 USD |
+0.61
|
$15.36B 16.79B USD | $680 743.33 USD | $8.25 9.02 USD | $8.25 9.02 USD | $15.36B 16.79B USD | 48.52 | $0.17 0.19 USD | |
| Astellas Pharma Inc. YPH.F | $8.25 9.02 USD |
+0.51
|
$15.36B 16.79B USD | $10 10.93 USD | $8.25 9.02 USD | $8.4 9.18 USD | $15.36B 16.79B USD | 48.51 | $0.17 0.19 USD | |
| Cipla Limited CIPLA.BO | $1,484.55 17.96 USD |
+1.18
|
$1.2T 14.51B USD | $20.13K 243.56 USD | $1,461.3 17.68 USD | $1,488.85 18.01 USD | $1.2T 14.51B USD | 22.77 | $65.17 0.79 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $50.6 55.31 USD |
-1.36
|
$10.62B 11.61B USD | $9 9.84 USD | $50.6 55.31 USD | $51.9 56.73 USD | $10.62B 11.61B USD | 25.30 | $2 2.19 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $50.85 55.59 USD |
-1.17
|
$10.62B 11.61B USD | $0 0 USD | $50.85 55.59 USD | $52 56.84 USD | $10.62B 11.61B USD | 25.42 | $2 2.19 USD | |
| CSPC Pharmaceutical CHJTF | $0.81 — |
0
|
$9.66B — | $20K — | $0.6199 — | $0.6199 — | $9.66B — | 16.19 | $0.05 — | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.7399 0.81 USD |
+2.7
|
$8.56B 9.36B USD | $1K 1.09K USD | $0.7399 0.81 USD | $0.7399 0.81 USD | $8.56B 9.36B USD | 14.88 | $0.05 0.05 USD | |
| CSPC Pharmaceutical Group Limited CVGU.F | $2.84 3.1 USD |
+2.9
|
$8.56B 9.36B USD | $500 546.57 USD | $2.84 3.1 USD | $2.84 3.1 USD | $8.56B 9.36B USD | 15.77 | $0.18 0.2 USD | |
| Orion Oyj ORINY | $33.03 — |
0
|
$9.26B — | $103 — | $32.45 — | $32.45 — | $9.26B — | 23.59 | $1.4 — | |
| Orion Oyj OFK0.F | $29.4 32.14 USD |
-0.68
|
$8.21B 8.98B USD | $0 0 USD | $29.4 32.14 USD | $29.4 32.14 USD | $8.21B 8.98B USD | 23.70 | $1.24 1.36 USD | |
| Orion Oyj OFK.F | $58.25 63.68 USD |
-1.1
|
$8.21B 8.98B USD | $83 90.73 USD | $58.25 63.68 USD | $58.8 64.28 USD | $8.21B 8.98B USD | 23.48 | $2.48 2.71 USD | |
| Grifols GIFLF | $10.45 — |
0
|
$8.03B — | $2.2K — | $9.52 — | $9.53 — | $8.03B — | 40.19 | $0.26 — | |
| Kyowa Kirin KYKOF | $15.23 — |
0
|
$8.01B — | $4 — | $16.5 — | $16.5 — | $8.01B — | 22.39 | $0.68 — | |
| Abbott India Limited ABBOTINDIA.NS | $30,795 372.57 USD |
-1.12
|
$654.86B 7.92B USD | $4.66K 56.33 USD | $30,750 372.02 USD | $31,245 378.01 USD | $654.86B 7.92B USD | 46.29 | $665.17 8.05 USD | |
| Abbott India Limited ABBOTINDIA.BO | $30,818 372.85 USD |
-0.9
|
$654.86B 7.92B USD | $74 0.9 USD | $30,760 372.14 USD | $31,046 375.6 USD | $654.86B 7.92B USD | 46.29 | $665.67 8.05 USD | |
| Kyowa Kirin Co., Ltd. KY4.F | $13.5 14.76 USD |
-0.74
|
$7.1B 7.76B USD | $50 54.66 USD | $13.4 14.65 USD | $13.5 14.76 USD | $7.1B 7.76B USD | 22.50 | $0.6 0.66 USD | |
| Orion Oyj ORINF | $48.65 — |
0
|
$7.63B — | $43 — | $47.16 — | $47.16 — | $7.63B — | 19.69 | $2.47 — | |
|
Aucune action favorite
Vous n'avez pas encore d'actions favorites, veuillez l'ajouter aux favoris pour la voir ici |
||||||||||
- {{ link.label }} {{link}}